Merck
CN
  • Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.

Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.

Journal of medicinal chemistry (2010-01-15)
Manthena V S Varma, R Scott Obach, Charles Rotter, Howard R Miller, George Chang, Stefanus J Steyn, Ayman El-Kattan, Matthew D Troutman
摘要

Oral bioavailability (F) is a product of fraction absorbed (Fa), fraction escaping gut-wall elimination (Fg), and fraction escaping hepatic elimination (Fh). In this study, using a database comprised of Fa, Fg, Fh, and F values for 309 drugs in humans, an analysis of the interrelation of physicochemical properties and the individual parameters was carried out in order to define the physicochemical space for optimum human oral bioavailability. Trend analysis clearly indicated molecular weight (MW), ionization state, lipophilicity, polar descriptors, and free rotatable bonds (RB) influence bioavailability. These trends were due to a combination of effects of the properties on Fa and first-pass elimination (Fg and Fh). Higher MW significantly impacted Fa, while Fg and Fh decreased with increasing lipophilicity. Parabolic trends were observed for bioavailability with polar descriptors. Interestingly, RB has a negative effect on all three parameters, leading to its pronounced effect on bioavailability. In conclusion, physicochemical properties influence bioavailability with typically opposing effects on Fa and first-pass elimination. This analysis may provide a rational judgment on the physicochemical space to optimize oral bioavailability.

材料
货号
品牌
产品描述

Sigma-Aldrich
地塞米松, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
利福平, ≥95% (HPLC), powder or crystals
Sigma-Aldrich
环丙沙星, ≥98% (HPLC)
Sigma-Aldrich
布洛芬, ≥98% (GC)
Sigma-Aldrich
羟基脲, 98%, powder
Sigma-Aldrich
甲氧苄啶, ≥98.5%
Sigma-Aldrich
吲哚美辛, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
红霉素, BioReagent, suitable for cell culture
Supelco
磺胺甲噁唑
Sigma-Aldrich
Levofloxacin, 98.0-102.0% anhydrous basis (HPLC)
Sigma-Aldrich
红霉素, meets USP testing specifications
Sigma-Aldrich
甲氧苄啶, ≥99.0% (HPLC)
Sigma-Aldrich
硝苯地平, ≥98% (HPLC), powder
Supelco
安替比林, analytical standard
Sigma-Aldrich
红霉素, potency: ≥850 μg per mg
Sigma-Aldrich
5-氟胞嘧啶, nucleoside analog
Sigma-Aldrich
酮洛芬, ≥98% (TLC)
Supelco
华法林, PESTANAL®, analytical standard
Sigma-Aldrich
磺胺嘧啶, 99.0-101.0%
Supelco
白消安, analytical standard, for drug analysis
Supelco
环丙沙星, VETRANAL®, analytical standard
Supelco
地高辛, analytical standard
Sigma-Aldrich
氧氟沙星, fluoroquinolone antibiotic
Supelco
甲苯磺丁脲, analytical standard
Supelco
华法林, analytical standard
Supelco
磺胺甲噁唑, VETRANAL®, analytical standard
Sigma-Aldrich
卡托普利, ≥98% (HPLC), powder
Supelco
磺胺嘧啶, VETRANAL®, analytical standard
Supelco
布洛芬
Sigma-Aldrich
5,5-二苯基海因, ≥98%